Understand the Revenue Behind the Numbers.
Financial statements reveal what a healthcare business has earned. They do not necessarily establish whether the underlying clinical documentation supports the reimbursement generating those earnings.
Clairnav provides specialized clinical revenue-integrity assessments for buyers of Medicare-certified home health agencies — tracing selected claims through the clinical documentation, coding, and assessment processes supporting payment to identify potential reimbursement exposure before closing.
Historical Claims
Reimbursement trends and anomalies
Clinical Evidence
Source-to-claim reconciliation
Transaction Risk
Decision-oriented findings
Paid does not always mean supported.
Healthcare acquisitions introduce a dimension of financial risk that conventional financial analysis may not fully address.
An agency may report consistent revenue, healthy margins, and reliable collections while maintaining weaknesses in the clinical documentation or reimbursement practices supporting historical claims.
That matters because Medicare reimbursement remains subject to retrospective review. Documentation or payment deficiencies can result in repayment exposure long after the original revenue was recognized.
Clairnav investigates the clinical evidence supporting historical reimbursement — not simply whether a claim was successfully submitted and paid.
Billing reconciliation can confirm the first three. Only source-level clinical review answers the fourth.
Trace the evidence.
Evaluate the exposure.
We examine the relationship between the patient's documented clinical history, the home health admission, the resulting assessments, the diagnosis coding, and the final reimbursement — following clinical information from source to paid claim.
Preceding Clinical Evidence
Physician documentation, hospital discharge records, and other clinical information establishing the patient's condition before admission.
Referral and Intake
How the agency received, interpreted, and documented the clinical information supporting the referral and admission.
Clinical Assessment & Care Documentation
Home health assessments, care plans, certifications, skilled-need documentation, and supporting clinical records.
Coding & Reimbursement Classification
Whether reported diagnoses and relevant reimbursement classifications are supported by the clinical evidence.
Claim & Payment Integrity
Discrepancies, recurring patterns, and potential payment-support deficiencies requiring further investigation.
Determine whether the documentation chain provides defensible support for selected reimbursement claims — and whether observed weaknesses may extend beyond individual records.
Clinical Revenue Integrity Due Diligence
Our principal engagement supports buyers evaluating Medicare-certified home health agencies, integrating historical claims-pattern analysis with targeted clinical record investigation to identify reimbursement vulnerabilities and the operational controls underlying them.
Comprehensive Clinical Revenue Integrity Due Diligence
Historical Reimbursement Analysis
Up to three years of available Medicare claims and reimbursement data, examined for unusual patterns, concentrations, and changes that warrant targeted investigation.
Source-to-Claim Clinical Record Review
Selected records evaluated for consistency and support across preceding documentation, physician referrals, home health assessments, diagnosis coding, and related claims.
Documentation & Payment-Support Assessment
Relevant Medicare requirements, including diagnosis support, homebound status, skilled need, face-to-face encounter documentation, and care-plan requirements.
Systemic Risk Identification
Whether observed deficiencies appear isolated or suggest weaknesses in the agency's intake, documentation, coding, or billing controls.
Transaction-Oriented Findings
A prioritized assessment of the nature and frequency of findings within reviewed records, potential reimbursement implications, and areas requiring further investigation.
Specialist Coordination
Findings and referrals to financial diligence providers, healthcare transaction counsel, reimbursement specialists, and clinical quality experts where additional expertise is required.
Focused Clinical Revenue Integrity Assessment
For transactions requiring a narrower initial investigation, a targeted assessment of selected reimbursement and documentation risks — designed to identify material questions that may justify expanded clinical or financial diligence.
Scope is tailored to the transaction, available records, and the buyer's immediate decision requirements.
Request an Assessment Scope →Expanded Investigations
Where initial findings indicate potential systemic weaknesses or significant reimbursement exposure, Clairnav supports additional record review, targeted workflow investigation, and specialist-led financial exposure analysis.
Separately scoped according to the findings and transaction requirements.
Discuss Expanded Scope →Engagements are scoped according to the transaction, payer mix, available clinical records, and required depth of investigation. Fixed-fee proposals are provided following an initial diligence discussion.
Findings that inform the transaction.
More than an inventory of coding or documentation discrepancies — our reporting connects the evidence examined to its potential implications for the acquisition.
A typical report includes
- An executive summary of material reimbursement-integrity concerns
- Historical claims-pattern observations and flagged anomalies
- Documented clinical evidence and coding discrepancies
- A prioritized Reimbursement Risk Register
- Findings categorized by severity and potential payment implications
- Indicators of recurring documentation or workflow weaknesses
- Areas requiring expanded financial, legal, or clinical review
- Recommended diligence actions and questions for seller management
Every material finding answers three questions
What did the evidence show?
The documented facts, traced to source records.
Why does it matter to reimbursement integrity?
The payment requirement or support standard implicated.
What should the acquisition team do next?
A specific, transaction-oriented recommendation.
Reimbursement Risk Register
| Ref | Finding | Evidence | Potential payment impact | Severity | Recommended transaction action |
|---|---|---|---|---|---|
| RR-01 | Primary diagnosis not supported by preceding clinical documentation | Hospital discharge summary documents a resolved condition; assessment and claim report it as the active primary diagnosis. | Possible change in clinical grouping and payment for affected periods | High | Expand sample within the same diagnosis group; request seller coding policies |
| RR-02 | Face-to-face encounter documentation incomplete | Encounter note lacks clinical findings related to the primary reason for home health services. | Payment-support deficiency for affected episodes | High | Quantify frequency; refer to transaction counsel regarding protections |
| RR-03 | Homebound status inconsistently documented | Visit notes describe activity levels inconsistent with the homebound determination. | Eligibility support risk | Medium | Interview clinical leadership; review intake and assessment workflow |
| RR-04 | Comorbidity coding concentrated within one intake pathway | Claims-pattern analysis shows elevated comorbidity adjustment rates for a single referral source. | Potentially systemic — coding control weakness | Medium | Targeted workflow investigation; share with financial diligence provider |
| RR-05 | Plan-of-care signature timing | Certifications signed after claim submission in a subset of reviewed records. | Payment-requirement timing deficiency | Low | Add to questions for seller management |
The result is a documented, decision-oriented assessment that can be incorporated into the broader transaction diligence process.
A defined specialist role within the transaction team.
Acquisition diligence requires multiple forms of expertise. Clairnav occupies the space between them.
Quality-of-Earnings Analysis
Evaluates reported financial performance and its sustainability.
Clinical Quality Review
Evaluates care delivery and relevant professional standards.
Healthcare Transaction Counsel
Evaluates legal and regulatory obligations, structure, and potential liabilities.
Clinical revenue integrityClairnav Advisory
Focuses on the clinical documentation and reimbursement integrity connecting care delivery to reported revenue.
Our findings help transaction teams identify where the underlying clinical evidence warrants closer examination — and where additional financial, legal, or clinical analysis may be necessary. We work directly with acquisition buyers or as an independent specialist within established healthcare M&A and diligence teams.
Historical claims can carry future consequences.
Medicare home health payments remain subject to federal oversight and retrospective review — which is why historical reimbursement practices deserve attention during an acquisition.
Claim paid
Documentation accepted at submission.
Revenue recognized
Reflected in reported earnings.
Acquisition closes
Valuation relies on historical revenue.
Retrospective review
Historical claims examined by auditors.
Repayment risk
Unsupported payments may be recouped.
Eligibility is grounded in the clinical record that precedes the claim.
CMS explicitly recognizes the role of the certifying physician's records and preceding acute and post-acute care records in supporting home health eligibility. Evaluating those records is central to understanding whether reimbursement is defensible.
Federal scrutiny of home health billing continues.
The Office of Inspector General continues to publish home health provider compliance audits identifying issues involving coding, face-to-face documentation, plans of care, and other payment requirements.
For buyers, the relevant question is not simply whether the target has collected its Medicare payments. It is whether material portions of that reimbursement are adequately supported — and whether identified weaknesses warrant additional investigation, financial analysis, or transaction protections.
Clairnav helps make those questions visible before the acquisition decision is finalized.
Led by an experienced healthcare information professional.
Clairnav was founded by Ariana Brandon to bring specialized healthcare information expertise into the acquisition diligence process — at the intersection of clinical documentation, coding, and health informatics.
Ariana brings approximately 20 years of healthcare experience across home health, outpatient, and inpatient coding environments, clinical documentation integrity, health information systems, and enterprise healthcare operations. That cross-setting background provides a perspective on how clinical information originates, moves between care environments, is interpreted by healthcare professionals, and ultimately influences coded and reimbursed claims.
Additional preparation includes postgraduate education in healthcare compliance and graduate study in health informatics.
Understanding a reimbursement discrepancy requires examining not only what was coded or billed, but how the underlying clinical information was interpreted, documented, and carried through the healthcare workflow.
Better questions. Better diligence.
Perspectives on clinical revenue integrity, documentation-dependent reimbursement risk, and the relationship between healthcare operations and acquisition economics.
Buying a Home Health Agency? Do You Know What Your Due Diligence Team Is Actually Reviewing?
A practical examination of the differences between billing reconciliation, clinical quality review, financial diligence, and source-to-claim documentation analysis.
Read the insight →The Audit That Arrives After Closing: Understanding Historical Medicare Reimbursement Exposure
Why retrospective payment reviews matter when evaluating the sustainability of a healthcare acquisition target's reported revenue.
Read the insight →
Evaluate more than the financial statements.
Whether you are acquiring your first Medicare-certified home health agency, evaluating a portfolio investment, or assembling a specialized diligence team, Clairnav can help you define the clinical reimbursement-integrity questions relevant to your transaction.
- Healthcare acquisition entrepreneurs and funded searchers
- Independent sponsors and investment groups
- Strategic acquirers and multi-agency operators
- Quality-of-earnings and transaction advisory firms
- Healthcare M&A attorneys seeking complementary clinical documentation expertise
San Francisco Bay Area · Serving Clients Nationally
Thank you.
Your inquiry has been received. Clairnav will follow up to arrange an initial conversation.